Akoya Biosciences, Inc. financial data

Symbol
AKYA on Nasdaq
Location
100 Campus Drive, 6 Th Floor, Marlborough, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 156 % -52.7%
Quick Ratio 49 % -8.46%
Debt-to-equity 1.26K % +478%
Return On Equity -506 % -310%
Return On Assets -37.2 % +4.15%
Operating Margin -48.2 % +27%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.9M shares +0.99%
Common Stock, Shares, Outstanding 49.8M shares +1.01%
Entity Public Float 61.7M USD
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49.7M shares +0.97%
Weighted Average Number of Shares Outstanding, Diluted 49.7M shares +0.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 80M USD -14.5%
Cost of Revenue 30.6M USD -25.7%
Research and Development Expense 19.7M USD -18.2%
Operating Income (Loss) -38.6M USD +37.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -47.4M USD +30.2%
Income Tax Expense (Benefit) 131K USD +77%
Net Income (Loss) Attributable to Parent -47.5M USD +30.1%
Earnings Per Share, Basic -1 USD/shares +32.4%
Earnings Per Share, Diluted -1 USD/shares +32.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.4M USD +56.1%
Marketable Securities, Current 7.19M USD -85.2%
Cash, Cash Equivalents, and Short-term Investments 27.5M USD -55.3%
Accounts Receivable, after Allowance for Credit Loss, Current 11.7M USD -12.8%
Inventory, Net 22.9M USD -0.59%
Other Assets, Current 4.07M USD +7.38%
Assets, Current 66.2M USD -35%
Property, Plant and Equipment, Net 6.92M USD -22.8%
Operating Lease, Right-of-Use Asset 3.86M USD -30.7%
Intangible Assets, Net (Excluding Goodwill) 13.8M USD -17.1%
Goodwill 18.3M USD 0%
Other Assets, Noncurrent 437K USD -33.2%
Assets 113M USD -27.2%
Accounts Payable, Current 10.3M USD -4.24%
Employee-related Liabilities, Current 3.05M USD -25.8%
Accrued Liabilities, Current 11.6M USD -7.14%
Contract with Customer, Liability, Current 6.52M USD -1.42%
Liabilities, Current 108M USD +226%
Contract with Customer, Liability, Noncurrent 2.78M USD -4.99%
Deferred Income Tax Liabilities, Net 140K USD +86.7%
Operating Lease, Liability, Noncurrent 3.41M USD -40.4%
Other Liabilities, Noncurrent 40K USD
Liabilities 119M USD -2.86%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD +93.8%
Retained Earnings (Accumulated Deficit) -301M USD -18.7%
Stockholders' Equity Attributable to Parent -5.89M USD -118%
Liabilities and Equity 113M USD -27.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.21M USD +65.4%
Net Cash Provided by (Used in) Financing Activities -250K USD +43.7%
Net Cash Provided by (Used in) Investing Activities 16M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 49.8M shares +1.01%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.58M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21M USD +53.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.12M USD -5.4%
Deferred Tax Assets, Valuation Allowance 63.1M USD +22.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 64.6M USD +20.8%
Operating Lease, Liability 6.11M USD -26.9%
Payments to Acquire Property, Plant, and Equipment 204K USD -74.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -47.5M USD +30.1%
Lessee, Operating Lease, Liability, to be Paid 6.82M USD -29.8%
Property, Plant and Equipment, Gross 19M USD +4.79%
Operating Lease, Liability, Current 2.71M USD +2.04%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.1M USD -58.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.62M USD -7.89%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 11K USD -70.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 704K USD -47.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 436K USD -60.5%
Deferred Tax Assets, Operating Loss Carryforwards 40.3M USD +28%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.79M USD +7.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four 449K USD +2.98%
Operating Lease, Payments 670K USD -6.69%
Additional Paid in Capital 295M USD +3.11%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.8M USD -12.3%
Deferred Tax Assets, Net of Valuation Allowance 1.57M USD -26.3%
Share-based Payment Arrangement, Expense 2.25M USD -12.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%